Repligen | RGEN

Peers Price Chg Day Year Date
A Agilent 136.33 -1.22 -0.89% 2.41% Apr/25
ALGN Align Technology 310.47 -4.11 -1.31% -12.43% Apr/25
BMRN BioMarin Pharmaceutical 82.17 -9.07 -9.94% -11.65% Apr/25
BMY Bristol-Myers Squibb 44.70 -4.16 -8.51% -34.28% Apr/25
BRKR Bruker 80.53 -1.67 -2.03% 3.92% Apr/25
CRL Charles River Laboratories 227.76 -11.87 -4.95% 21.79% Apr/25
CTLT Catalent 55.80 -0.14 -0.25% 31.73% Apr/25
DHR Danaher 245.47 -4.90 -1.96% 5.59% Apr/25
EXAS Exact Sciences 58.79 -4.45 -7.04% -6.21% Apr/25
FLDM Standard Biotools 2.36 -0.06 -2.48% 43.03% Apr/25
GE General Electric 161.25 1.77 1.11% 67.60% Apr/25
HSIC Henry Schein 72.83 -0.37 -0.50% -10.32% Apr/25
ILMN Illumina 121.03 -1.85 -1.51% -42.63% Apr/25
IQV IQVIA Holdings 233.48 -7.37 -3.06% 22.90% Apr/25
MTD Mettler Toledo International 1,234.98 0.28 0.02% -15.51% Apr/25
MYGN Myriad Genetics 17.99 -0.64 -3.44% -14.25% Apr/25
PDCO Patterson Companies 25.80 -0.38 -1.45% -2.16% Apr/25
PFE Pfizer 25.26 -0.97 -3.69% -34.61% Apr/25
PKI Revvity 102.32 -0.52 -0.51% -19.76% Apr/25
RGEN Repligen 165.70 -2.16 -1.29% 11.48% Apr/25
TECH Bio Techne 62.68 -0.91 -1.43% -20.39% Apr/25
TMO Thermo Fisher Scientific 571.73 -6.35 -1.10% 7.24% Apr/25
WAT Waters 308.53 -1.57 -0.51% 5.40% Apr/25
WST West Pharmaceutical Services 368.66 -17.78 -4.60% 3.20% Apr/25
XRAY Dentsply International 30.35 -0.60 -1.92% -25.85% Apr/25

Indexes Price Day Year Date
CCMP USND 15612 -100.99 -0.64% 31.70% Apr/25
RTY US2000 1981 -14.31 -0.72% 13.13% Apr/26
MID US400 2887 -13.99 -0.48% 18.79% Apr/25

Repligen traded at $165.70 this Thursday April 25th, decreasing $2.16 or 1.29 percent since the previous trading session. Looking back, over the last four weeks, Repligen lost 9.87 percent. Over the last 12 months, its price rose by 11.48 percent. Looking ahead, we forecast Repligen to be priced at 180.41 by the end of this quarter and at 170.27 in one year, according to Trading Economics global macro models projections and analysts expectations.

Repligen Corporation is a life sciences company that develops and commercializes bioprocessing technologies and systems that rises flexibility in the process of manufacturing biological drugs. The Company's bioprocessing business consist of four franchises, Filtration; Chromatography; Process Analytics; and Proteins. The Filtration products are used in process development and process scale (clinical and commercial) production. The Chromatography franchise includes products used in downstream purification, development, and manufacturing of biological drugs. The Process Analytics products allow end-users to make in-line absorbance measurements allowing for the determination of protein concentration in filtration, chromatography formulation and fill-finish applications. The Proteins franchise is represented by its Protein A affinity ligands, which are a critical component of Protein A chromatography resins used in downstream purification of virtually all mAb-based drugs on the market.